Proteinuria may be an indicator of adverse pregnancy outcomes in patients with preeclampsia: a retrospective study

Table 3 Comparison of adverse fetal outcomes

	Non-PE	PE	p value	Subgroups^c			p value
	Non-PE	PE	p value	A	B	C	p value
Number^a	54	275	–	53	64	53	–
Adverse fetal outcomes (%)	13 (24.1)	124 (45.1)	0.004	16 (30.2)	19 (30.0)	36 (67.9)	< 0.001
Induced labour (%)	2 (3.7)	19 (6.9)	0.378	1 (1.9)	4 (6.2)	10 (18.9)	0.006
Premature (< 37 week)	3 (5.6)	56 (20.4)	0.010	15 (28.3)	7 (10.9)	18 (34.0)	0.009
FGR (%)	0	24 (8.7)	0.024	3 (5.7)	5 (7.8)	6 (11.3)	0.563
Low birth weight^b (%)	0	28 (10.2)	0.014	6 (11.3)	4 (6.2)	4 (7.5)	0.596
Oligohydramnios (%)	0	29 (10.5)	0.012	6 (11.3)	8 (12.5)	3 (5.7)	0.437
Stillbirth (%)	1 (1.9)	16 (5.8)	0.229	0	3 (4.7)	9 (17.0)	0.002
Neonatal asphyxia (%)	0	10 (3.6)	0.155	0	2 (3.1)	3 (5.7)	0.225
Neonatal hypoxic encephalopathy (%)	1 (1.9)	1 (0.4)	0.198	0	0	1 (1.9)	0.329
Fetal malformation (%)	2 (3.7)	2 (0.7)	0.068	1 (1.9)	0	1 (1.9)	0.043
Fetal distress (%)	4 (7.4)	23 (8.4)	0.815	1 (1.9)	4 (6.3)	5 (9.4)	0.253
Birth weight (g)	3157.46 ± 494.72	2878.16 ± 709.86	0.008	2872.02 ± 559.15	3010.25 ± 607.36	2444.76 ± 871.95	0.001

Number^a: The number of multiple adverse pregnancy outcomes was counted according to the types of adverse pregnancy outcomes
Low birth weight^b: including light for date infant and premature low birth weight infants, FGR Fetal Growth Restriction; Subgroups^c: A: 24-h urinary protein < 0.3 g; B:24-h urinary protein 0.3 ~ 2 g; C:24-h urinary protein ≧ 2 g

ISSN: 1477-7827